{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:03:51Z","timestamp":1792688631704,"version":"4.5.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010409","name":"Children's Investment Fund Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Reprod. Health"],"abstract":"<jats:p>Women of reproductive age need multipurpose prevention technology (MPT) products to address two overlapping health risks: unintended pregnancy and HIV. Currently, condoms are the only available MPT, however male condoms are not within the control of a woman, and the use of female condoms has been limited by low acceptability and cost. Oral pre-exposure prophylaxis (PrEP) is highly effective for HIV prevention, yet uptake and adherence among women have been low to date. Women globally need more options for HIV and pregnancy prevention. Several MPTs for simultaneous HIV and pregnancy prevention are in various stages of development and clinical testing, although most are many years away from market launch. A dual prevention pill (DPP), a daily oral pill combining oral contraceptives and PrEP, both of which are licensed, approved products in many low- and middle-income countries (LMIC), is likely to be the fastest route to getting an MPT product into the hands of women. The DPP is one option that could enhance method choice, particularly for women who are already using oral contraceptives. By leveraging the oral contraceptive market and reaching women currently using condoms or with an unmet need for contraception, the DPP has the potential to increase the uptake of PrEP. The successful rollout of the DPP will require careful consideration of user-, provider-, and product-centered factors during product development and introduction. Early attention to these interrelated factors can help ensure that the DPP has the ideal characteristics for maximum product acceptability, that effective and quality services are designed and implemented, and that users can make informed choices, demand the product, and use it effectively. The proposed framework outlines key considerations for the effective development and introduction of the DPP, which could also facilitate integration models for future MPTs.<\/jats:p>","DOI":"10.3389\/frph.2021.682689","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T04:27:27Z","timestamp":1624422447000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["The Promise of the Dual Prevention Pill: A Framework for Development and Introduction"],"prefix":"10.3389","volume":"3","author":[{"given":"Barbara A.","family":"Friedland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanyukta","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa B.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"B1","unstructured":"SullyEA\n            BiddlecomA\n            DarrochJE\n            RileyT\n            AshfordLS\n            Lince-DerocheN\n          Guttmacher InstituteAdding it up: Investing in Sexual and Reproductive Health 20192020"},{"key":"B2","unstructured":"UNAIDSGlobal HIV & AIDS statistics \u2014 2020 Fact Sheet"},{"key":"B3","first-page":"628","article-title":"Integration of prevention and care of sexually transmitted infections with family planning services: what is the evidence for public health benefits?","volume":"78","author":"Dehne","year":"2000","journal-title":"Bull World Health Organ."},{"key":"B4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.2471\/BLT.08.059279","article-title":"Progress on scaling up integrated services for sexual and reproductive health and HIV","volume":"87","author":"Dickinson","year":"2009","journal-title":"Bull World Health Organ."},{"key":"B5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/sifp.12018","article-title":"Integration of family planning services into HIV care and treatment services: a systematic review: integration of family planning into HIV treatment services","volume":"48","author":"Haberlen","year":"2017","journal-title":"Stud Fam Plann."},{"key":"B6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12978-019-0709-6","article-title":"Effective integration of sexual reproductive health and HIV prevention, treatment, and care services across sub-Saharan Africa: where is the evidence for program implementation?","volume":"16","author":"Kangudie","year":"2019","journal-title":"Reprod Health."},{"key":"B7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/sifp.12024","article-title":"The current status of research on the integration of sexual and reproductive health and HIV services: the current status of SRH-HIV integration research","volume":"48","author":"Warren","year":"2017","journal-title":"Stud Fam Plann."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1779632","DOI":"10.1080\/26410397.2020.1779632","article-title":"Sexual and reproductive health services in universal health coverage: a review of recent evidence from low- and middle-income countries","volume":"28","author":"Ravindran","year":"2020","journal-title":"Sex Reprod Health Matters."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/j.antiviral.2013.09.016","article-title":"Prioritizing multipurpose prevention technology development and investments using a target product profile","volume":"100","author":"Romano","year":"2013","journal-title":"Antiviral Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/j.antiviral.2013.09.029","article-title":"Designing a multipurpose technology for acceptability and adherence","volume":"100","author":"Tolley","year":"2013","journal-title":"Antiviral Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/790154","article-title":"Developing multipurpose reproductive health technologies: an integrated strategy","volume":"2013","author":"Harrison","year":"2013","journal-title":"AIDS Res Treat."},{"key":"B12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.tim.2015.02.006","article-title":"Multipurpose prevention technologies: the future of HIV and STI protection","volume":"23","author":"Fern\u00e1ndez-Romero","year":"2015","journal-title":"Trends Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/1471-0528.12850","article-title":"The future of multipurpose prevention technology product strategies: understanding the market in parallel with product development","volume":"121","author":"Romano","year":"2014","journal-title":"BJOG Int J Obstet Gynaecol."},{"key":"B14","unstructured":"End-user opinions about the future of HIV prevention: results from a global internet survey about Multipurpose Prevention Technologies (MPTs)\n            PlagianosM\n            KallianesV\n            SavelC\n            PickettJ\n            GuthrieK\n            MartinezC\n          MadridHIV Res Prevention Conference2018"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e25094","DOI":"10.1002\/jia2.25094","article-title":"The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention","volume":"21","author":"van der Straten","year":"2018","journal-title":"J Int AIDS Soc."},{"key":"B16","unstructured":"IPSOSAssessing the Potential of MPTs in South Africa, Uganda and Nigeria2014"},{"key":"B17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10461-017-1913-4","article-title":"A randomized crossover study evaluating the use and acceptability of the SILCS diaphragm compared to vaginal applicators for vaginal gel delivery","volume":"22","author":"Beksinska","year":"2018","journal-title":"AIDS Behav."},{"key":"B18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10461-017-1977-1","article-title":"Impact of the dapivirine vaginal ring on sexual experiences and intimate partnerships of women in an HIV prevention clinical trial: managing ring detection and hot sex","volume":"22","author":"Laborde","year":"2018","journal-title":"AIDS Behav"},{"key":"B19","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/09540121.2016.1224296","article-title":"Beyond the syndemic: condom negotiation and use among women experiencing partner violence","volume":"29","author":"Peasant","year":"2017","journal-title":"AIDS Care."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1186\/1471-2458-12-1097","article-title":"Role of condom negotiation on condom use among women of reproductive age in three districts in Tanzania","volume":"12","author":"Exavery","year":"2012","journal-title":"BMC Public Health."},{"key":"B21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/OAJC.S55041","article-title":"Knowledge, attitudes, practices and behaviors associated with female condoms in developing countries: a scoping review","volume":"6","author":"Moore","year":"2015","journal-title":"Open Access J Contracept."},{"key":"B22","unstructured":"MPT Product Development Database"},{"key":"B23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/17425247.2020.1728251","article-title":"Vaginal multipurpose prevention technologies: promising approaches for enhancing women's sexual and reproductive health","volume":"17","author":"Fernandes","year":"2020","journal-title":"Expert Opin Drug Deliv."},{"key":"B24","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.antiviral.2013.09.019","article-title":"Lessons from reproductive health to inform multipurpose prevention technologies: don't reinvent the wheel","volume":"100","author":"Brady","year":"2013","journal-title":"Antiviral Res."},{"key":"B25","volume-title":"Contraceptive Use by Method 2019: Data Booklet (ST\/ESA\/SER.A\/435)","year":"2019"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjsrh-2020-200662","article-title":"Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake","author":"Begg","year":"2020","journal-title":"BMJ Sex Reprod Health."},{"key":"B27","article-title":"Uptake of PrEP within clinics providing integrated family planning and PrEP services: results from a large implementation program in Kenya","volume-title":"Oral Abstract Presentation (TUAC0304)","author":"Mugwanya","year":"2018"},{"key":"B28","article-title":"Integrating oral HIV pre-exposure prophylaxis (PrEP) in a public family planning facility and youth center to inform national roll out in Zimbabwe","volume-title":"Oral Abstract Presentation (TUAC0307LB)","author":"Gombe","year":"2018"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e25298","DOI":"10.1002\/jia2.25298","article-title":"HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery","volume":"22","author":"Celum","year":"2019","journal-title":"J Int AIDS Soc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10461-016-1458-y","article-title":"Experiences with HPTN 067\/ADAPT study-provided open-label PrEP among women in Cape Town: facilitators and barriers within a mutuality framework","volume":"21","author":"Amico","year":"2017","journal-title":"AIDS Behav"},{"key":"B31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/QAI.0000000000001762","article-title":"HIV pre-exposure prophylaxis stigma as a multidimensional barrier to uptake among women who attend planned parenthood","volume":"79","author":"Calabrese","year":"2018","journal-title":"J Int AIDS Soc."},{"key":"B32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/QAI.0000000000000880","article-title":"Participants' explanations for non-adherence in the FEM-PrEP clinical trial","volume":"71","author":"Corneli","year":"2016","journal-title":"J Int AIDS Soc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0246717","DOI":"10.1371\/journal.pone.0246717","article-title":"Relationship dynamics and anticipated stigma: key considerations for PrEP use among Tanzanian adolescent girls and young women and male partners","volume":"16","author":"Jani","year":"2021","journal-title":"PLoS ONE."},{"key":"B34","article-title":"How long will they take it?","volume-title":"Oral abstract presentation (WEAE0403)","author":"Kyongo","year":"2018"},{"key":"B35","unstructured":"PopulationCouncil\n          Developing an Oral Contraceptive and HIV-Prevention Method, in a Single Pill"},{"key":"B36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2307\/2138111","article-title":"The strategic approach to contraceptive introduction","volume":"28","author":"Simmons","year":"1997","journal-title":"Stud Fam Plann."},{"key":"B37","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.contraception.2015.08.007","article-title":"Meaning-making matters in product design: users' sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings","volume":"92","author":"Rosen","year":"2015","journal-title":"Contraception."},{"key":"B38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10461-017-1911-6","article-title":"End-users' product preference across three multipurpose prevention technology delivery forms: baseline results from young women in Kenya and South Africa","volume":"22","author":"Weinrib","year":"2018","journal-title":"AIDS Behav."},{"key":"B39","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s13346-017-0385-4","article-title":"On-demand microbicide products: design matters","volume":"7","author":"Patel","year":"2017","journal-title":"Drug Deliv Transl Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/hbe2.195","article-title":"The theory of planned behavior: frequently asked questions","volume":"2","author":"Ajzen","year":"2020","journal-title":"Hum Behav Emerg Technol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.1016\/S2352-3018(16)30115-1","article-title":"PrEP introduction for adolescent girls and young women","volume":"3","author":"Mathur","year":"2016","journal-title":"Lancet HIV."},{"key":"B42","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/COH.0b013e3283590632","article-title":"Acceptability in microbicide and PrEP trials: current status and a reconceptualization","volume":"7","author":"Mensch","year":"2012","journal-title":"Curr Opin HIV AIDS."},{"key":"B43","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.contraception.2014.05.015","article-title":"Acceptability of the Nestorone\u00ae\/ethinyl estradiol contraceptive vaginal ring: development of a model; implications for introduction","volume":"90","author":"Merkatz","year":"2014","journal-title":"Contraception."},{"key":"B44","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.amepre.2005.02.020","article-title":"The multiple layers of prevention science research","volume":"28","author":"MacQueen","year":"2005","journal-title":"Am J Prev Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/1471-0528.12845","article-title":"Lessons learnt from sexual and reproductive health and HIV linkages for multipurpose prevention technology service delivery","volume":"121","author":"Lusti-Narasimhan","year":"2014","journal-title":"BJOG Int J Obstet Gynaecol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12978-019-0749-y","article-title":"Male partner influence on family planning and contraceptive use: perspectives from community members and healthcare providers in KwaZulu-Natal, South Africa","volume":"16","author":"Kriel","year":"2019","journal-title":"Reprod Health."},{"key":"B47","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/QAI.0000000000002463","article-title":"Prevention, partners, and power imbalances: women's views on how male partners affected their adherence to vaginal microbicide gels during HIV Prevention Trials in Africa","volume":"85","author":"Miller","year":"2020","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1080\/13691058.2015.1030451","article-title":"To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa","volume":"17","author":"Kelly","year":"2015","journal-title":"Cult Health Sex."},{"key":"B49","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12978-018-0561-0","article-title":"There might be blood: a scoping review on women's responses to contraceptive-induced menstrual bleeding changes","volume":"15","author":"Polis","year":"2018","journal-title":"Reprod Health."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0217333","DOI":"10.1371\/journal.pone.0217333","article-title":"Potential user interest in new long-acting contraceptives: results from a mixed methods study in Burkina Faso and Uganda","volume":"14","author":"Callahan","year":"2019","journal-title":"PLoS ONE."},{"key":"B51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/COH.0000000000000221","article-title":"Planning for HIV preexposure prophylaxis introduction: lessons learned from contraception","volume":"11","author":"Delany-Moretlwe","year":"2016","journal-title":"Curr Opin HIV AIDS."}],"container-title":["Frontiers in Reproductive Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2021.682689\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T04:27:45Z","timestamp":1624422465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2021.682689\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":51,"alternative-id":["10.3389\/frph.2021.682689"],"URL":"https:\/\/doi.org\/10.3389\/frph.2021.682689","relation":{},"ISSN":["2673-3153"],"issn-type":[{"value":"2673-3153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,23]]},"article-number":"682689"}}